molecular diagnostics
Through detailed molecular diagnosis, subgroups of diseases can be defined and targeted treatments can be developed. For example, it is thus possible to treat patients with cancer or autoimmune diseases with very specific acting therapeutic antibodies.
The company BioTeZ Berlin-Buch GmbH has developed a monitoring system with which for the first time physicians can determine during treatment what effect the drug has on the individual patient and what dosage he/she still needs. Thus, the treatment can be optimized for the individual patient, which may in the end also be much more cost effective.
INVITEK Molecular GmbH offers customized solutions for the manual and automatic preparation of samples for molecular biological diagnostic methods, such as DNA and RNA analysis. Nucleic acid isolation and purification are offered by IST Innuscreen GmbH. The company’s portfolio also includes molecular biological reagent systems as well as technologies and products for molecular diagnostics.
Molecular diagnostics also have applications in food technology: The company aokin AG is specialized in rapid precision analysis of toxins: With the aokin system, mold in grain shipments can be identified within minutes. Congen Biotechnologie GmbH develops and produces PCR-based detection methods for agricultural and food analysis. This makes it possible to identify genetically modified plants, allergens or pathogenic bacteria and viruses.
News innovation
Biosynth Expands Berlin Site with a New Commercial Bioconjugation Suite
The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply.
more ...Cutting the environmental impact of research
From reducing freezer usage to plastic waste, Max Delbrück Center labs have been implementing strategies from the LEAF program for sustainable research. As more labs join the program, they are not onl...
more ...Biomedical innovation in Berlin gets €30 million boost
The Helmholtz Association has approved €30.8 million in funding for the Center for AI–Accelerated Molecular Innovations in Medicine to be located at the Max Delbrück Center. Researchers will use new t...
more ...Events Campus
09.09.2025, 09:00
From Target to Market - The BBA Biotech & Pharma Summer School
The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea to the market.
more ...23.09.2025, 09:00
GMP Biotech Summer School
Good Manufacturing Practice (GMP) Basic Course Biotechnology (English) & ATMPs
more ...
